PMDA drug package insert
ネオシネジンコーワ注1mg
PMDA Prescription drug · 興和株式会社 · package insert May 25, 2026
Key facts
| Brand names | ネオシネジンコーワ注1mg, ネオシネジンコーワ注5mg |
|---|---|
| Nonproprietary names | フェニレフリン塩酸塩 |
| Companies | 製造販売元／興和株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 血管収縮・血圧上昇剤 |
| Therapeutic category codes | 87216 |
| YJ codes | 2160400A1032, 2160400A2039 |
| Approval numbers | 21700AMZ00056, 21700AMZ00055 |
| Package insert edition | 第2版 |
| Package insert date | May 25, 2026 |
| PMDA document key | 270072_2160400A1032_1 |
| PMDA company code | 270072 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: